Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;4(6):257-66.
doi: 10.1159/000354097. Epub 2013 Aug 21.

Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema

A Mendola, M J Schlögel, A Ghalamkarpour, A Irrthum, H L Nguyen, E Fastré, A Bygum, C van der Vleuten, C Fagerberg, E Baselga, I Quere, J B Mulliken, L M Boon, P Brouillard, M Vikkula; Lymphedema Research Group

Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema

A Mendola et al. Mol Syndromol. 2013 Sep.

Abstract

Lymphedema is caused by dysfunction of lymphatic vessels, leading to disabling swelling that occurs mostly on the extremities. Lymphedema can be either primary (congenital) or secondary (acquired). Familial primary lymphedema commonly segregates in an autosomal dominant or recessive manner. It can also occur in combination with other clinical features. Nine mutated genes have been identified in different isolated or syndromic forms of lymphedema. However, the prevalence of primary lymphedema that can be explained by these genetic alterations is unknown. In this study, we investigated 7 of these putative genes. We screened 78 index patients from families with inherited lymphedema for mutations in FLT4, GJC2, FOXC2, SOX18, GATA2, CCBE1, and PTPN14. Altogether, we discovered 28 mutations explaining 36% of the cases. Additionally, 149 patients with sporadic primary lymphedema were screened for FLT4, FOXC2, SOX18, CCBE1, and PTPN14. Twelve mutations were found that explain 8% of the cases. Still unidentified is the genetic cause of primary lymphedema in 64% of patients with a family history and 92% of sporadic cases. Identification of those genes is important for understanding of etiopathogenesis, stratification of treatments and generation of disease models. Interestingly, most of the proteins that are encoded by the genes mutated in primary lymphedema seem to act in a single functional pathway involving VEGFR3 signaling. This underscores the important role this pathway plays in lymphatic development and function and suggests that the unknown genes also have a role.

Keywords: Functional pathway; Genetic; Mutation; Phenotype.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Scheme for the genetic analysis of lymphedema patients. WES = Whole exome sequencing.
Fig. 2
Fig. 2
The functions of the proteins encoded by the genes mutated in primary lymphedema cluster around a central molecular pathway: the VEGFR3 signaling.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–249. - PMC - PubMed
    1. Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41:1272–1274. - PubMed
    1. Alders M, Mendola A, Ades L, Al Gazali L, Bellini C, et al. Evaluation of clinical manifestations in patients with severe lymphedema with and without CCBE1 mutations. Mol Syndromol. 2013;4:107–113. - PMC - PubMed
    1. Au AC, Hernandez PA, Lieber E, Nadroo AM, Shen YM, et al. Protein tyrosine phosphatase PTPN14 is a regulator of lymphatic function and choanal development in humans. Am J Hum Genet. 2010;87:436–444. - PMC - PubMed
    1. Bell R, Brice G, Child AH, Murday VA, Mansour S, et al. Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet. 2001;108:546–551. - PubMed